Medicare Enrolled
Dr. James Freidenstein, MD
Interventional Pain Medicine Physician · St Augustine, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Freidenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Freidenstein? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Freidenstein
Dr. James Freidenstein is an interventional pain medicine physician in St Augustine, FL, with 17 years in practice. Based on federal Medicare data, Dr. Freidenstein performed 11,403 Medicare services across 3,734 unique beneficiaries.
Between the years covered by Open Payments, Dr. Freidenstein received a total of $12,335 from 60 pharmaceutical and/or device companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Freidenstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 12% volume in FL$ $12,335 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,403
Medicare services
Top 12% in FL for interventional pain medicine physician
3,734
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~671 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) | 1,630 | $1 | $4 |
| Dexamethasone injection (steroid) | 1,624 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,421 | $91 | $372 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 1,280 | $63 | $242 |
| Office visit, established patient (20-29 min) | 915 | $67 | $263 |
| Drug injection, under skin or into muscle | 770 | $11 | $41 |
| Drug screening test | 748 | $61 | $186 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 506 | $152 | $343 |
| Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | 210 | $23 | $88 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 200 | $194 | $343 |
| Chronic care management, additional 20 min/month | 181 | $37 | $137 |
| Chronic care management, first 20 min/month | 164 | $49 | $182 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 161 | $103 | $368 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 148 | $234 | $889 |
| Fluoroscopic guidance for needle placement | 134 | $88 | $334 |
| Joint injection, major joint | 119 | $51 | $207 |
| Injection, ketorolac tromethamine, per 15 mg | 112 | $0 | $4 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 100 | $192 | $697 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 96 | $256 | $831 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 93 | $103 | $359 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 89 | $495 | $1,651 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 84 | $163 | $599 |
| New patient office visit (45-59 min) | 80 | $122 | $488 |
| Insertion of spinal neurostimulator electrode array through skin | 68 | $245 | $1,227 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 67 | $209 | $707 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 58 | $107 | $365 |
| New patient office visit (30-44 min) | 50 | $82 | $329 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 43 | $269 | $972 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 39 | $481 | $1,836 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 38 | $110 | $343 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 37 | $406 | $1,743 |
| Injection of trigger points, 3 or more muscles | 22 | $45 | $180 |
| Injection of substance into middle or upper spine canal using imaging guidance | 21 | $190 | $753 |
| Injection of substance into lower spine canal using imaging guidance | 18 | $199 | $741 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 15 | $222 | $1,019 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | 14 | $112 | $471 |
| Office visit, established patient (10-19 min) | 13 | $34 | $164 |
| Insertion of spinal neurostimulator generator or receiver | 12 | $159 | $1,098 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 12 | $374 | $1,396 |
| Advance care planning consultation, first 30 min | 11 | $78 | $242 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,335
Total received (2018-2024)
Avg $1,762/year across 7 years
Top 22% in FL for interventional pain medicine physician
60
Companies
442
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,195 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$139 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,140
2023$3,186
2022$2,734
2021$1,362
2020$651
2019$1,582
2018$1,680
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,907
Relievant Medsystems, Inc.
$1,196
ABBVIE INC.
$1,148
Nevro Corp.
$764
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$726
Flowonix Medical Incorporated
$503
Amgen Inc.
$400
Medtronic, Inc.
$374
Collegium Pharmaceutical, Inc.
$293
AbbVie Inc.
$284
Curonix LLC
$282
Abbott Laboratories
$280
PFIZER INC.
$214
Biohaven Pharmaceuticals, Inc.
$187
SPR Therapeutics, Inc
$186
TerSera Therapeutics LLC
$181
Stimwave Technologies Incorporated
$169
Flexion Therapeutics, Inc.
$160
BioDelivery Sciences International, Inc.
$152
Biohaven Pharmaceutical Holding Company Ltd.
$119
BOSTON SCIENTIFIC CORPORATION
$114
Lundbeck LLC
$109
Zimmer Biomet Holdings, Inc.
$107
Lilly USA, LLC
$105
Pernix Therapeutics Holdings, Inc.
$104
Allergan Inc.
$96
Allergan, Inc.
$83
Avanos Medical
$73
Teva Pharmaceuticals USA, Inc.
$63
Novartis Pharmaceuticals Corporation
$63
ARBOR PHARMACEUTICALS, INC.
$60
Egalet US Inc
$55
ASSERTIO THERAPEUTICS, Inc.
$54
Bioventus LLC
$53
Zyla Life Sciences
$50
AstraZeneca Pharmaceuticals LP
$49
Zyla Life Sciences, Inc.
$44
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$43
Daiichi Sankyo Inc.
$41
Horizon Therapeutics plc
$36
SI-BONE, INC.
$35
Virtus Pharmaceuticals LLC
$33
Stryker Corporation
$32
Almatica Pharma LLC
$29
Medtronic USA, Inc.
$29
Purdue Pharma L.P.
$27
PROTEGA PHARMACEUTIALS LLC
$25
Radius Health, Inc.
$23
Nalu Medical, Inc.
$21
Nuvectra Corporation
$18
Pacira Pharmaceuticals Incorporated
$18
GRT US Holding, Inc.
$17
USWM, LLC
$16
Saluda Medical Americas, Inc.
$16
Sentynl Therapeutics, Inc.
$15
RedHill Biopharma Inc.
$13
Covidien LP
$12
US WorldMeds, LLC
$12
Horizon Pharma plc
$11
Kaleo, Inc.
$11
Top 3 companies account for 42.6% of total payments
Associated products mentioned in payments ›
32 CONTACT · ADAPTIVESTIM · AIMOVIG · AJOVY · ARYMO ER · Aimovig · Algovita · BELBUCA · BIONIC NAVIGATOR · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Bionic Navigator · CFNS StimQ Peripheral Nerve StimulatorSystem · DUEXIS · DUROLANE · Durolane · EMGALITY · ETERNA · EVZIO · Evoke · FORTEO · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · Gel One · Gel-One Cross-linked Hyaluronate · General - Pain Management · Gralise · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Iovera · KRYSTEXXA · LEVORPHANOL TARTRATE · LYRICA · Levorphanol · Lucemyra · Lucemyra/Lofexidine · MILD DEVICE KIT · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Prometra II · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · Roxybond · SCS IPGs · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · Situate · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion Indirect Decompression System · TREXIMET · UBRELVY · VISCO-3 · VYEPTI · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZORVOLEX · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $108 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
4
Per 100K population
1.4
County median income
$106,169
Nearest hospital
FLAGLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Freidenstein is a clinical cardiology specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Freidenstein experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Freidenstein performed 1,630 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Freidenstein receive payments from pharmaceutical companies?
Yes. Dr. Freidenstein received a total of $12,335 from 60 companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Freidenstein's costs compare to other interventional pain medicine physicians in St Augustine?
Dr. Freidenstein's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Freidenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in St Augustine
Browse interventional pain medicine physicians in St Augustine ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in FL
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in FL
Which FL interventional pain medicine physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Relievant Medsystems, Inc. Payments to Doctors
See all physicians who received payments from Relievant Medsystems, Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology